TTK Healthcare Ltd Q2 FY26 – “From Gripe Water to Gripe Investors: How a 99-Year-Old Brand Still Can’t Find a Profit Center”
1. At a Glance
If Indian corporates were school children, TTK Healthcare would be the obedient kid who brings all his notebooks to class but still ends up with “Needs Improvement” on the report card. With a market cap of ₹1,649 crore, trading around ₹1,167, this 99-year-old brand house manages to cover everything from baby burps (Woodward’s Gripe Water) to adult adventures (Skore condoms).
ROE = 6.9 %, ROCE = 9.3 %, debt = ₹27 crore, P/E ≈ 23×, and an OPM of 3.3 %. One could call it diversified; auditors call it confused but cash-rich.
2. Introduction
There are conglomerates that reinvent themselves every decade; TTK Healthcare just reinvents the packaging. Born out of the legendary TT Krishnamachari Group, cousin to TTK Prestige, this company sells nostalgia, not disruption.
Between Gripe Water that your grandmother swore by and Skore condoms your college crush might have endorsed, TTK has perfected the art of existing in every Indian household without anyone noticing its share price.
After selling its Human Pharma Division for ₹805 crore in FY23, the company now sits on cash, sipping dividends like Woodward’s tonic. Yet profits are flatter than a papad from its own Foods Division.
3. Business Model – WTF Do They Even Do?
Think of TTK Healthcare as an FMCG buffet: five counters, mixed returns, and a manager who insists “sab business chalta hai.”
Divisions (FY24 revenue mix)
Consumer Products (31 %) – Woodward’s Gripe Water, Eva Deo, Good Home, Skore. 4 lakh outlets, 27 warehouses, and 650 salespeople all chasing a 3 % operating margin.
Protective Devices (27 %) – The Skore brand dominates the “fun with latex” segment. Launched MsChief for women – because diversity, apparently.
